Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the pair's weight loss drug partnership fell apart. Investors are eyeing Micron's (MU) third quarter results after the closing bell. Stay ...

Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the pair's weight loss drug partnership fell apart. Investors are eyeing Micron's (MU) third quarter results after the closing bell. Stay ...

Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the pair's weight loss drug partnership fell apart. Investors are eyeing Micron's (MU) third quarter results after the closing bell. Stay ...

On behalf of an individual investor, Block & Leviton LLP filed a class action lawsuit today against Hims & Hers Health, Inc. (NYSE: HIMS), along with certain individuals, alleging that they violated ...

Glancy Prongay & Murray LLP ("GPM"), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Sookdeo v. Hims & Hers ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.

Granted, defense is not a new theme. The Global X Defense Tech ETF SHLD, which has hot plays including Palantir Technologies (PLTR) and Germany's Rheinmetall (XE:RHM), has surged 54% this year. The ...

Shares in Denmark's pharmaceutical giant Novo Nordisk ( NVO -4.99%) were lower by 4% as of 11 a.m. ET today. The move comes ...

Synthetic food dyes are added to 1 in 5 packaged foods and drinks sold by top U.S. food manufacturers, a new study says.